Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy.
CAT# | R1116 |
CAS | 168650-46-2 |
Synonyms/Alias | Tyrosinase |
M.F/Formula | C₄₂H₆₆N₁₀O₁₆S₂ |
M.W/Mr. | 1031.16 |
Sequence | One Letter Code: YMDGTMSQV three Letter Code: Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val |
Areas of Interest | Antigen-presenting Cells; Cancer Research |
Disease | Melanoma |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
GRK2i, a GRK2 inhibitory polypeptide, specifically inhibits Gβγ activation of GRK2. It corresponds to the Gβγ-bi ...
Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...
ProTx II, a 30-amino acid, disulfide-rich peptide toxin, isolated from the venom of the tarantula, Thrixopelma ...
Gap 19 is a nonapeptide derived from the cytoplasmic loop (CL) of Connexin-43 (Cx43). Cx43 is a predominant card ...
PR 39, a porcine 39-aa peptide antibiotic, was originally isolated from the upper part of the small intestine o ...